MRSA

DCN Dx acquires Biomed Diagnostics
The purchase expands DCN Dx's reach into the point-of-use testing and sampling market by adding a number of tests to its portfolio, including InPouch TV for detection of Trichomonas vaginalis, Transport Media (VTM) for SARS-CoV-2 sample transport, and InTray VS COLOREX for testing for methicillin-resistant Staphylococcus aureus (MRSA).
April 24, 2022
2020 02 21 19 47 4640 Lab Petri Microbiology 400
Labcorp launches smart laboratory test reports
The reports are available for diseases that have significant health risks on their own or as co-morbidities for other conditions, such as diabetes and chronic kidney disease. Labcorp has also created reports for conditions that impact hospitalizations, such as community-acquired methicillin-resistant Staphylococcus aureus (MRSA).
July 8, 2020
2020 07 09 20 19 5888 Data Analytics Charts 400
FDA clears Roche's novel MRSA nasal swab test
The agency cleared the cobas vivoDx MRSA test through the de novo premarket review pathway. Along with the Roche authorization, the FDA established special controls for these types of diagnostics, including requirements related to labeling and design verification and validation to address certain risks, such as false positives. The FDA's action also creates a new regulatory classification, which means that subsequent devices of the same type with the same intended use may apply through the 510(k) pathway.
December 4, 2019
2019 12 05 22 45 7027 Mrsa Bacteria Cdc 400
Luminex MRSA test clears FDA
The Aries MRSA assay tests directly for MRSA DNA from nasal swabs in patients at risk for nasal colonization. Clearance was granted on September 25 and announced by the company on October 1.
September 30, 2019
2019 08 20 21 21 4020 Luminex Aacc 2019 400
Most Popular
Genetic causes identified for three rare diseases
Researchers in study validate test to identify newborns with homocystinuria, a rare inherited disease
FDA reissues EUA for Janssen COVID-19 vaccine, includes warning about risks of myocarditis, pericarditis
National hepatitis C elimination program represents an historic opportunity, according to White House
Chicago man indicted for COVID-19 testing fraud
Netherlands researchers combine CRISPR, bioluminescence in proof-of-concept infectious disease test
Page 1 of 1